Trial Profile
A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Eperisone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 12 Dec 2013 New source identified and integrated (Korean Clinical Trials Register; KCT0000925).
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2013 New trial record